Here are some biotech song requests for Diana Ross at the 2018 BIO convention
This June, some 16,000 people will descend on the Boston Convention& Exhibition Center for the BIO International Convention, a closely-watched annual gathering that gives biotech companies another platform to pitch themselves to investors and each other. And they’ll be joined by a special guest: Diana Ross. The Biotechnology Innovation Organization, the lobbying group that organizes the event, announced on Wednesday that the Motown star and former lead singer of The Supremes will perform a concert… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 15, 2018 Category: American Health Authors: Max Stendahl Source Type: news

Study points to potential misuse/abuse of ADHD drugs
(Wiley) A new British Journal of Clinical Pharmacology study indicates that methylphenidate, a central nervous system stimulant approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, may be subject to misuse and/or abuse. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 7, 2018 Category: International Medicine & Public Health Source Type: news

Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - February 14, 2018 Category: Drugs & Pharmacology Source Type: news

Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta(R)
BRIDGEWATER, N.J., Feb. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals has launched methylphenidate hydrochloride extended-release tablets, USP (CII) in 18, 27, 36, and 54 mg strengths. Amneal's methylphenidate is an AB-rat... Biopharmaceuticals, Generics, Product Launch Amneal Pharmaceuticals, methylphenidate, Concerta (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2018 Category: Pharmaceuticals Source Type: news

Cotempla XR ODT (Methylphenidate Extended-Release Orally Disintegrating Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 31, 2018 Category: Drugs & Pharmacology Source Type: news

Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - January 22, 2018 Category: Drugs & Pharmacology Source Type: news

Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension (New - Currently in Shortage
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - January 22, 2018 Category: Drugs & Pharmacology Source Type: news

Young Women Are Using A.D.H.D. Drugs in Greater Numbers, C.D.C. Reports
Since 2003, the percentage of women filling prescriptions for drugs like Ritalin has increased nearly fivefold in some age groups. (Source: NYT Health)
Source: NYT Health - January 18, 2018 Category: Consumer Health News Authors: BENEDICT CAREY Tags: Attention Deficit Hyperactivity Disorder Women and Girls Drugs (Pharmaceuticals) Pregnancy and Childbirth Centers for Disease Control and Prevention Source Type: news

ADHD drug tied to heart defects in babies
(Reuters Health) - - Pregnant women who take drugs like Ritalin and Concerta for attention deficit hyperactivity disorder (ADHD) are more likely than those who don ’t to have babies with heart deformities and other birth defects, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - January 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Ritalin During Pregnancy May Raise Risk of Heart Defect in Baby
A new study found a small increased risk of having a baby with a heart defect if Ritalin/Concerta  (methylphenidate) was taken by the mother-to-be. (Source: WebMD Health)
Source: WebMD Health - December 13, 2017 Category: Consumer Health News Source Type: news

Ritalin During Pregnancy May Raise Risk of Heart Defect in Baby
Source: HealthDay Related MedlinePlus Pages: Attention Deficit Hyperactivity Disorder, Congenital Heart Defects, Pregnancy and Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 13, 2017 Category: Consumer Health News Source Type: news

ADHD drug use in pregnancy increases risk of heart defects, study finds
The attention-deficit hyperactivity disorder drug methylphenidate is associated with an increased risk of heart defects in infants whose mothers take the medication during pregnancy, according to a study published Wednesday in the journal JAMA Psychiatry. (Source: CNN.com - Health)
Source: CNN.com - Health - December 13, 2017 Category: Consumer Health News Source Type: news

ADHD medication could cause birth defects
Children exposed to ADHD drugs like Ritalin in the first trimester are more likely to have heart deformities, according to a new study by the Brigham and Women's Hospital. (Source: the Mail online | Health)
Source: the Mail online | Health - December 13, 2017 Category: Consumer Health News Source Type: news

ADHD Meds During Pregnancy Appear To Have Low Risk Of Birth Defects
Most ADHD medications appear to have no increased risk for birth defects except a very small increased risk for heart defects with methylphenidate use in the first trimester. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 13, 2017 Category: Pharmaceuticals Authors: Tara Haelle, Contributor Source Type: news

Ritalin During Pregnancy May Raise Risk of Heart Defect in Baby
WEDNESDAY, Dec. 13, 2017 -- If you take Ritalin or Concerta for attention-deficit/hyperactivity disorder (ADHD) and you plan to become pregnant, you might want to talk to your doctor about switching your medication first. A new study found a small... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 13, 2017 Category: General Medicine Source Type: news